Wird geladen...
Changes in Inflammatory Biomarkers in Patients Treated With Ticagrelor or Clopidogrel
BACKGROUND: Inflammation is a key factor in the development of atherosclerotic disease and acute coronary syndromes (ACS). The P2Y(12) receptor antagonists ticagrelor (AZD6140) and clopidogrel may have anti‐inflammatory effects. The objective of this analysis from the Dose Confirmation Study Assessi...
Gespeichert in:
Veröffentlicht in: | Clin Cardiol |
---|---|
Hauptverfasser: | , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Wiley Periodicals, Inc.
2010
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653411/ https://ncbi.nlm.nih.gov/pubmed/20394040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20732 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|